New Senior Investment Group Inc (SNR)

8.82  -0.1 (-1.12%)

After market: 8.82 0 (0%)

Fundamental Rating

0

Overall SNR gets a fundamental rating of 0 out of 10. We evaluated SNR against 127 industry peers in the Diversified REITs industry. SNR has a bad profitability rating. Also its financial health evaluation is rather negative. SNR is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

SNR had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -1.56%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 9.48%
PM (TTM) -8.4%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

SNR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SNR has a Debt/Equity ratio of 8.12. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 8.12
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SNR have decreased strongly by -225.00% in the last year.
The Revenue has decreased by -5.64% in the past year.
The Revenue has been decreasing by -2.84% on average over the past years.
EPS 1Y (TTM)-225%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-300%
Revenue 1Y (TTM)-5.64%
Revenue growth 3Y1.2%
Revenue growth 5Y-2.84%
Revenue growth Q2Q-6.44%

3.2 Future

SNR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.92% yearly.
SNR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.21% yearly.
EPS Next Y-211.11%
EPS Next 2Y-45.3%
EPS Next 3Y6.92%
EPS Next 5Y-10.92%
Revenue Next Year-2.71%
Revenue Next 2Y-0.15%
Revenue Next 3Y1.54%
Revenue Next 5Y2.21%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNR. In the last year negative earnings were reported.
Also next year SNR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.3%
EPS Next 3Y6.92%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.95%, SNR has a reasonable but not impressive dividend return.
SNR's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.95%

5.2 History

The dividend of SNR decreases each year by -16.19%.
SNR has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-16.19%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

SNR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
SNR's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-88.1%
EPS Next 2Y-45.3%
EPS Next 3Y6.92%

More info and screens

New Senior Investment Group Inc

NYSE:SNR (9/20/2021, 7:24:19 PM)

After market: 8.82 0 (0%)

8.82

-0.1 (-1.12%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap741.44M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.95%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.56%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 9.48%
PM (TTM) -8.4%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 8.12
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-225%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-211.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.64%
Revenue growth 3Y1.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y